Literature DB >> 6526015

Transformation of mammalian fibroblasts and macrophages in vitro by a murine retrovirus encoding an avian v-myc oncogene.

B Vennström, P Kahn, B Adkins, P Enrietto, M J Hayman, T Graf, P Luciw.   

Abstract

A murine retrovirus which expresses the avain v-myc OK10 oncogene was constructed. The virus, denoted MMCV, readily transforms fibroblasts of established lines, such as mouse NIH/3T3 and rat 208F cells, to anchorage-independent growth in agarose. The virus also transforms primary mouse cells: (i) virus-infected macrophages are induced to form large colonies in semi-solid media, and can easily be expanded into mass cultures; (ii) MMCV-infected fibroblastic cells from mouse limb buds undergo morphological transformation and grow in semi-solid medium. MMCV thus transforms both mouse fibroblastic cells and macrophages in vitro, in a fashion similar to the v-myc-containing avian viruses in chicken cells. The possibility of introducing a transforming myc gene into mammalian cells by virus infection provides a novel approach for studying the mechanism of myc transformation in cells from many lineages.

Entities:  

Mesh:

Year:  1984        PMID: 6526015      PMCID: PMC557841          DOI: 10.1002/j.1460-2075.1984.tb02282.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  50 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  Transformation parameters in chicken fibroblasts transformed by AEV and MC29 avian leukemia viruses.

Authors:  B Royer-Pokora; H Beug; M Claviez; H J Winkhardt; R R Friis; T Graf
Journal:  Cell       Date:  1978-04       Impact factor: 41.582

3.  Construction and characterization of a 2.5-kilobase procollagen clone.

Authors:  H Lehrach; A M Frischauf; D Hanahan; J Wozney; F Fuller; R Crkvenjakov; H Boedtker; P Doty
Journal:  Proc Natl Acad Sci U S A       Date:  1978-11       Impact factor: 11.205

4.  Two types of target cells for transformation with avian myelocytomatosis virus.

Authors:  T Graf
Journal:  Virology       Date:  1973-08       Impact factor: 3.616

5.  Plasminogen activator production accompanies loss of anchorage regulation in transformation of primary rat embryo cells by simian virus 40.

Authors:  R Pollack; R Risser; S Conlon; D Rifkin
Journal:  Proc Natl Acad Sci U S A       Date:  1974-12       Impact factor: 11.205

6.  Response of bone marrow to MC29 avian leukosis virus in vitro.

Authors:  A J Langlois; R B Fritz; U Heine; D Beard; D P Bolognesi; J W Beard
Journal:  Cancer Res       Date:  1969-11       Impact factor: 12.701

7.  3-acetylpyridine: effects in vitro related to teratogenic activity in chicken embryos.

Authors:  A I Caplan; E Zwilling; N O Kaplan
Journal:  Science       Date:  1968-05-31       Impact factor: 47.728

8.  Effects of the nicotinamide-sensitive teratogen3-acetylpyridine on chick limb cells in culture.

Authors:  A I Caplan
Journal:  Exp Cell Res       Date:  1970-10       Impact factor: 3.905

9.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

10.  An improved technique for obtaining enhanced infectivity with herpes simplex virus type 1 DNA.

Authors:  N D Stow; N M Wilkie
Journal:  J Gen Virol       Date:  1976-12       Impact factor: 3.891

View more
  32 in total

1.  An avian retrovirus expressing chicken pp59c-myc possesses weak transforming activity distinct from v-myc that may be modulated by adjacent normal cell neighbors.

Authors:  E J Filardo; E H Humphries
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

2.  Retrovirus-mediated gene transfer to purified hemopoietic stem cells with long-term lympho-myelopoietic repopulating ability.

Authors:  S J Szilvassy; C C Fraser; C J Eaves; P M Lansdorp; A C Eaves; R K Humphries
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

3.  Cooperative transforming activities of ras, myc, and src viral oncogenes in nonestablished rat adrenocortical cells.

Authors:  A MacAuley; T Pawson
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

Review 4.  Control of myogenic differentiation by cellular oncogenes.

Authors:  M D Schneider; E N Olson
Journal:  Mol Neurobiol       Date:  1988       Impact factor: 5.590

5.  The putative transforming protein of S13 avian erythroblastosis virus is a transmembrane glycoprotein with an associated protein kinase activity.

Authors:  M J Hayman; G Kitchener; P K Vogt; H Beug
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

6.  Differential transformation of C3H10T1/2 cells by v-mos: sequential expression of transformation parameters.

Authors:  F A van der Hoorn; V Müller
Journal:  Mol Cell Biol       Date:  1985-09       Impact factor: 4.272

7.  Partial reversion of conditional transformation correlates with a decrease in the sensitivity of rat cells to killing by the parvovirus minute virus of mice but not in their capacity for virus production: effect of a temperature-sensitive v-src oncogene.

Authors:  N Salome; B van Hille; M Geuskens; J Rommelaere
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

8.  Potentiation of growth factor activity by exogenous c-myc expression.

Authors:  V Sorrentino; V Drozdoff; M D McKinney; L Zeitz; E Fleissner
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

9.  Coinfection with viruses carrying the v-Ha-ras and v-myc oncogenes leads to growth factor independence by an indirect mechanism.

Authors:  M Vogt; J Lesley; J Bogenberger; S Volkman; M Haas
Journal:  Mol Cell Biol       Date:  1986-10       Impact factor: 4.272

10.  The human homolog of the JE gene encodes a monocyte secretory protein.

Authors:  B J Rollins; P Stier; T Ernst; G G Wong
Journal:  Mol Cell Biol       Date:  1989-11       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.